Tufts Medicine Names Accomplished Healthcare Leader as New CEO
December 11, 2019
Tufts Medicine today announced that Michael J. Dandorph will become the president and chief executive officer of the growing health system, effective January 2020. In this role, Dandorph will unite more than 15,000 Tufts Medicine employees and clinicians in the common goal of integrating academic medicine and high-quality care across all health care members, physician groups and the communities they serve. Dandorph was selected for this executive position after an extensive national search.
Dandorph joins Tufts Medicine after serving as president of Rush University System for Health and Rush University Medical Center, a leading health system in the metropolitan Chicago area that employs 15,000 people across several medical centers, more than 30 regional outpatient locations, and a fully integrated health science university.
“Mike’s professional experience includes virtually every facet of the health care landscape from large academic medical centers to smaller community hospitals and health plans,” said Ellen Zane, Chair of the Board of Trustees at Tufts Medicine. “Beyond Mike’s proven ability to develop and grow successful health systems, he is an innovative strategist and collaborator whose inclusive attitude will enable our teams to further enhance the lasting impacts we make on the lives of our patients and the health care community as a whole.”
Under Dandorph’s leadership, Rush elevated its quality rankings and patient satisfaction scores to within the top decile of the nation, reduced patient safety events by 40 percent over three years, expanded the system’s clinical enterprise by more than $900 million in operating revenues, and navigated a system-wide strategic plan focused on expanding its reach while simultaneously addressing health equity gaps in the diverse communities it serves.
“It is an absolute honor to be selected by the Tufts Medicine board to lead the health system at such an important time of change in health care. Having met with many board members, dozens of physicians and numerous clinical and administrative leaders across Tufts Medicine’s esteemed entities, I am incredibly impressed with every team member’s commitment to compassionate, patient-centric care,” Dandorph said. “It was the people I met who showed me that Tufts Medicine is well positioned to deliver on the promise to create a true and distinctive partnership between academic and community medicine, one that distributes the most advanced health care services to benefit the diverse individuals and communities it serves now and for the long-term. I look forward to collaborating with my new colleagues and creating other innovative partnerships for Tufts Medicine. Together, we will propel a new vision for health care – one that provides care that is of the highest quality, is conveniently accessible, and reduces the economic burden for consumers and the business community in the Boston region and beyond.”
Before being named President at Rush, Dandorph spent three years as chief operating officer and executive vice president for clinical affairs. He also spent more than 17 years at the University of Pennsylvania Health System (Penn Medicine) where he led Penn’s managed care efforts, created robust network affiliations and partnerships, and expanded clinical programs across the Philadelphia region as senior vice president of strategy and business development.
Dandorph replaces Norm Deschene who retired in December 2018. Since then, Michael Wagner, MD has served as interim Tufts Medicine CEO and will return to his position as chief physician executive for Tufts Medicine in January.
Dandorph and his wife, Jean, have three college-aged children and look forward to finding a new home in Massachusetts.